Brain focused treatment 2 nd CNN Department of Urology, Kyoto Prefectural University of Medicine Akihiro Kawauchi, M.D., Ph.D.
Nocturnal enuresis : Voiding during sleep Causes: Sleep (including nocturnal polyuria), bladder or both
Brain focused treatment?
The Health-related Quality of Life in patients and mothers of patients with nocturnal enuresis
The health-related quality of life in enuretic children evaluated before and after treatment (Kid-kindle) Emotional well-being Family Friend Physical well-being Self-esteem School 0.02 Before treatment 16.6± ± ± ± ± ± ± ± ± ± ± ±3.2 Healthy volunteers After treatment P value** Before treatment vs. Healthy volunteers P value* Before vs. after treatment Domain ± ± ± ± ± ± * paired-t test* * t test J Urol, in press
Role physical Social functioning General health Physical functioning Body pain Vitality 91.9± ± ± ± ± ± ± ± ± ± ± ±17.2 Role emotional Mental health 89.9 ± ± ± ±16.8 The health-related quality of life in mothers of enuretic children evaluated before and after treatment (SF36) Before treatment Healthy volunteers Domain ± ± ± ± ± ± ±17.6 After treatment 92.5±8.8 P value** Before treatment vs. Healthy volunteers P value* Before vs. after treatment * paired-t test * * t test J Urol, in press
The health-related quality of life in mothers of enuretic children evaluated with STAI and SDS before and after treatment Before treatment Healthy volunteers After treatment SDS 42.0 ±7.8 STAI state trait 37.3 ± ± ± ± ± ± ± ± P value** Before treatment vs. Healthy volunteers P value* Before vs. after treatment * paired-t test * * t test J Urol, in press
Sleep and bladder
Dynamic change in bladder capacities in 24 nonenuretics and 36 enuretics Urology, 2003 Capacity (ml) Functional Bladder Capacity (FBC) Nocturnal Bladder Capacity (NBC) Enuretic Bladder Capacity (EBC)
EBC (ml) P< 0.01 P< P< 0.05 Changes in enuretic bladder capacity (EBC) during alarm therapy Enuresis, 1997
Sleep and Desmopressin
Effect of DDAVP on awakening ability XX X X X X ○ ○ June/ ○ : Awakening without wetting × : Bedwetting Time Am ○ ○ DDAVP 20μg
Latero-dorsal tegmental nucleus (LDT) response to administration of DDAVP intravenous injection Direct administration Urology 2004
To establish “Brain focused treatment”, causes of NE in CNS should be clarified.